Silverberg Bernstein Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Silverberg Bernstein Capital Management's PFE Position: Q3 2026 in Review
Silverberg Bernstein Capital Management reduced its Pfizer (PFE) stake by 1.7% in Q3 2026, selling an estimated $10.6K and leaving 22,883 shares worth $653K. The position accounts for 0.31% of the portfolio, ranked #43.
Silverberg Bernstein Capital Management first reported a position in PFE in Q3 2024 and has held it in 9 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Silverberg Bernstein Capital Management held 22,883 shares of Pfizer worth $653K as of Q3 2026.
- Silverberg Bernstein Capital Management sold 400 Pfizer shares in Q3 2026, an estimated $10.6K.
- Pfizer made up 0.31% of Silverberg Bernstein Capital Management's portfolio in Q3 2026, its #43 holding.
- Silverberg Bernstein Capital Management first reported a position in Pfizer in Q3 2024 and has held it in 9 quarters since.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Silverberg Bernstein Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.